Literature DB >> 1977096

Influence of neurohypophyseal peptides on the formation of active avoidance conditioned reflex behavior.

R Sh Ibragimov1.   

Abstract

The role of lysine-vasopressin and oxytocin, as well as of their analog and fragment (DGAVP, desglycinamide arginine vasopressin; PLG, prolyl-leucyl-glycyl-amine), microinjected into the ventral hippocampus, in the formation and extinction of active avoidance conditioned reflex, was investigated. It was established that the introduction of lysine-vasopressin, as well as of its analog, into the hippocampus promoted the improvement of the formation of the avoidance reaction, while an inhibitory effect was elicited in the period of extinction of the skill. The opposite effects on the active avoidance reaction were obtained with oxytocin and its fragments. It is hypothesized that the observed behavioral changes in the active avoidance reaction are associated with the influence of these peptides on the processes of learning and memory.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977096     DOI: 10.1007/bf01195453

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  10 in total

Review 1.  Peptides and behavior.

Authors:  D de Wied
Journal:  Life Sci       Date:  1977-01-15       Impact factor: 5.037

2.  Effect of lysine vasopressin and ACTH 4-10 on conditioned avoidance behavior of hypophysectomized rats.

Authors:  B Bohus; W H Gispen; D De Wied
Journal:  Neuroendocrinology       Date:  1973       Impact factor: 4.914

3.  Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress.

Authors:  D M Gibbs
Journal:  Life Sci       Date:  1984-07-30       Impact factor: 5.037

4.  [3H]oxytocin binding sites in the rat brain demonstrated by quantitative light microscopic autoradiography.

Authors:  R E Brinton; J K Wamsley; K W Gee; Y P Wan; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

5.  Neurohypophyseal peptide levels in CSF and plasma during passive avoidance behavior in rats.

Authors:  W B Mens; M A van Egmond; A A de Rotte; T B van Wimersma Greidanus
Journal:  Horm Behav       Date:  1982-12       Impact factor: 3.587

6.  Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.

Authors:  G L Kovács; B Bohus; D H Versteeg; E R de Kloet; D de Wied
Journal:  Brain Res       Date:  1979-10-19       Impact factor: 3.252

7.  Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord.

Authors:  R M Buijs
Journal:  Cell Tissue Res       Date:  1978-09-26       Impact factor: 5.249

8.  Vasopressin accelerates appetitive discrimination learning and impairs its reversal.

Authors:  S J Sara; J Barnett; P Toussaint
Journal:  Behav Processes       Date:  1982-06       Impact factor: 1.777

9.  Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?

Authors:  A Ettenberg; D van der Kooy; M Le Moal; G F Koob; F E Bloom
Journal:  Behav Brain Res       Date:  1983-03       Impact factor: 3.332

10.  [Effect of neurohypophyseal peptides on the formation of a conditioned feeding reflex in the rat].

Authors:  G G Gasanov; G Telegdi; R Sh Ibragimov; T Kadar
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1986 Sep-Oct       Impact factor: 0.437

  10 in total
  2 in total

Review 1.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

Authors:  Andreas Meyer-Lindenberg; Gregor Domes; Peter Kirsch; Markus Heinrichs
Journal:  Nat Rev Neurosci       Date:  2011-08-19       Impact factor: 34.870

2.  Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans.

Authors:  A Meyer-Lindenberg; B Kolachana; B Gold; A Olsh; K K Nicodemus; V Mattay; M Dean; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-05-20       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.